April 06, 2022 Corporate News

• 7E Investments Appoints Lauren Wells as Vice President, Investor Relations and Strategy
•  
• Bloom Ads Global Media Group Selected as Agency of Record for Clean Juice
•  
• Start a Business in 2022 with an Ori'Zaba Franchise Opportunity
•  
• Transgistics Talent Reports Peak Demand for Final Mile High Performance Leadership
•  
• Digital Door Lock System Market to Expand at CAGR of 14.3% During Forecast Period, Observes TMR Study
•  
• Statement by NextEra Energy Resources President and CEO and NextEra Energy Partners President Rebecca Kujawa on agreement between the U.S. Department of Justice and ESI Energy
•  
• Kia America debuta en Estados Unidos elnuevo Niro 2023 en el New York International Auto Show
•  
• Gas Generator Market Size to Grow by USD 3.61bn | Increasing Instances of Power Grid Failure to Drive Growth | Technavio
•  
• Jets donating $1 million to aid relief efforts in Ukraine
•  
• Bobby Rydell, 60s teen idol and 'Bye Bye Birdie' star, dies
•  
• Parents of former US Marine say hope diminishing for son's release from Russia
•  
• Defense secretary, GOP congressman clash over alleged 'wokeism' in military
•  
• Germany seizes world's largest illegal market on darknet with US help
•  
• Henderson Properties Launches Henderson Investment Group
•  
• Solar Panels Installation in Melbourne, Ecorelief
•  
• Purchase Unique Gift Hampers From Hamper Lounge
•  
• BIS Footwear Regulation for India Webinar, from SGS
•  
• NIX United Participating in Swift Heroes
•  
• Crononomics Comes in First for Gaming and Decentralized Applications on the Cronos Network
•  
• Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
•